Vivani Medical, Inc. Common Stock (DE)
VANIVivani Medical, Inc. (VANI) is a biotechnology company focused on developing innovative solutions for the treatment of chronic conditions. The firm specializes in advanced drug delivery systems and regenerative medicine technologies aimed at improving patient outcomes and quality of life.
Company News
Vivani Medical is raising approximately $15.7 million through a registered direct offering of 6 million shares and a private placement of 3.7 million shares at $1.62 per share. The proceeds will fund research, clinical development, and general corporate purposes.
EmergingGrowth.com announces the schedule for the 78th Emerging Growth Conference, featuring presentations from various companies across different growth sectors.
Vivani Medical plans to initiate the first clinical study for its NPM-115 program, a 6-month GLP-1 implant for chronic weight management, in Australia in Q4 2024. The study will evaluate the safety, tolerability, and pharmacokinetic profile of the exenatide implant compared to weekly semaglutide injections and Bydureon BCise.
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin. Bitdeer Technologies Group shares jumped 10.2% to $7.45 on Monda...
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. Zscaler posted better-than-expected earnings and sales results for its second quarter on Thursday. The company said it expects fiscal year 2024 non-GAAP income from operations between $395 million and $400 million and net income p...
